Large-scale expression and purification of the major HIV-1 coreceptor CCR5 and characterization of its interaction with RANTES

Protein Expression and Purification

Volumn 61, Issue 2, 2008, Pages 155-162

  Nisius, Lydia ^a   Rogowski, Marco ^a   Vangelista, Luca ^b   Grzesiek, Stephan ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Baculovirus; CCR5; CD; GPCR; HIV 1; ITC; Membrane protein; NMR; RANTES; Secondary structure; Sf9 cells

Indexed keywords

CHEMOKINE RECEPTOR CCR5; LIGAND; MONOCLONAL ANTIBODY; RANTES; RECOMBINANT PROTEIN;

ANIMAL; ANTIBODY SPECIFICITY; ARMYWORM; ARTICLE; BACULOVIRUS; BINDING COMPETITION; BINDING SITE; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; CYTOLOGY; DIMERIZATION; GENE VECTOR; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; MICELLE; PROTEIN PROCESSING; PROTEIN SECONDARY STRUCTURE; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BACULOVIRIDAE; BINDING SITES; BINDING, COMPETITIVE; CELLS, CULTURED; CHEMOKINE CCL5; DIMERIZATION; GENETIC VECTORS; HIV-1; HUMANS; LIGANDS; MICELLES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, CCR5; RECOMBINANT PROTEINS; SPODOPTERA; STRUCTURE-ACTIVITY RELATIONSHIP;

HEXAPODA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 50049098838     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2008.06.001     Document Type: Article

References (39)

1. Pierce K.L., Premont R.T., and Lefkowitz R.J. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3 (2002) 639-650
2. Wise A., Gearing K., and Rees S. Target validation of G-protein coupled receptors. Drug Discov. Today 7 (2002) 235-246
3. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le Trong I., Teller D.C., Okada T., Stenkamp R.E., Yamamoto M., and Miyano M. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289 (2000) 739-745
4. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., Choi H.J., Kuhn P., Weis W.I., Kobilka B.K., and Stevens R.C. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318 (2007) 1258-1265
5. Rasmussen S.G., Choi H.J., Rosenbaum D.M., Kobilka T.S., Thian F.S., Edwards P.C., Burghammer M., Ratnala V.R., Sanishvili R., Fischetti R.F., Schertler G.F., Weis W.I., and Kobilka B.K. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450 (2007) 383-387
6. Raport C.J., Gosling J., Schweickart V.L., Gray P.W., and Charo I.F. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha. J. Biol. Chem. 271 (1996) 17161-17166
7. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., and Berger E.A. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272 (1996) 1955-1958
8. Sodhi A., Montaner S., and Gutkind J.S. Viral hijacking of G-protein-coupled-receptor signalling networks. Nat. Rev. Mol. Cell Biol. 5 (2004) 998-1012
9. Scarlatti G., Tresoldi E., Bjorndal A., Fredriksson R., Colognesi C., Deng H.K., Malnati M.S., Plebani A., Siccardi A.G., Littman D.R., Fenyo E.M., and Lusso P. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat. Med. 3 (1997) 1259-1265
10. Littman D.R. Chemokine receptors: keys to AIDS pathogenesis?. Cell 93 (1998) 677-680
11. Paterlini M.G. Structure modeling of the chemokine receptor CCR5: implications for ligand binding and selectivity. Biophys. J. 83 (2002) 3012-3031
12. Huang C.C., Lam S.N., Acharya P., Tang M., Xiang S.H., Hussan S.S., Stanfield R.L., Robinson J., Sodroski J., Wilson I.A., Wyatt R., Bewley C.A., and Kwong P.D. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 317 (2007) 1930-1934
13. Cocchi F., DeVico A., Garzinodemo A., Arya S.K., Gallo R.C., and Lusso P. Identification of Rantes, Mip-1-Alpha, and Mip-1-Beta as the Major Hiv-Suppressive Factors Produced by Cd8(+) T-Cells. Science 270 (1995) 1811-1815
14. Polo S., Nardese V., De Santis C., Arcelloni C., Paroni R., Sironi F., Verani A., Rizzi M., Bolognesi M., and Lusso P. Enhancement of the HIV-1 inhibitory activity of RANTES by modification of the N-terminal region: dissociation from CCR5 activation. Eur. J. Immunol. 30 (2000) 3190-3198
15. Nardese V., Longhi R., Polo S., Sironi F., Arcelloni C., Paroni R., DeSantis C., Sarmientos P., Rizzi M., Bolognesi M., Pavone V., and Lusso P. Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES. Nat. Struct. Biol. 8 (2001) 611-615
16. Hartley O., Gaertner H., Wilken J., Thompson D., Fish R., Ramos A., Pastore C., Dufour B., Cerini F., Melotti A., Heveker N., Picard L., Alizon M., Mosier D., Kent S., and Offord R. Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors. Proc. Natl. Acad. Sci. USA 101 (2004) 16460-16465
17. Farzan M., Mirzabekov T., Kolchinsky P., Wyatt R., Cayabyab M., Gerard N.P., Gerard C., Sodroski J., and Choe H. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 96 (1999) 667-676
18. Bannert N., Craig S., Farzan M., Sogah D., Santo N.V., Choe H., and Sodroski J. Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines. J. Exp. Med. 194 (2001) 1661-1673
19. Duma L., Haussinger D., Rogowski M., Lusso P., and Grzesiek S. Recognition of RANTES by extracellular parts of the CCR5 receptor. J. Mol. Biol. 365 (2007) 1063-1075
20. Blanpain C., Wittamer V., Vanderwinden J.M., Boom A., Renneboog B., Lee B., Le Poul E., El Asmar L., Govaerts C., Vassart G., Doms R.W., and Parmentier M. Palmitoylation of CCR5 is critical for receptor trafficking and efficient activation of intracellular signaling pathways. J. Biol. Chem. 276 (2001) 23795-23804
21. Springael J.Y., Urizar E., and Parmentier M. Dimerization of chemokine receptors and its functional consequences. Cytokine Growth Factor Rev. 16 (2005) 611-623
22. Jin H., Shen X., Baggett B.R., Kong X., and LiWang P.J. The human CC chemokine MIP-1beta dimer is not competent to bind to the CCR5 receptor. J. Biol. Chem. 282 (2007) 27976-27983
23. Tate C.G., and Grisshammer R. Heterologous expression of G-protein-coupled receptors. Trends Biotechnol. 14 (1996) 426-430
24. Sarramegna V., Talmont F., Demange P., and Milon A. Heterologous expression of G-protein-coupled receptors: comparison of expression systems from the standpoint of large-scale production and purification. Cell. Mol. Life Sci. 60 (2003) 1529-1546
25. Akermoun M., Koglin M., Zvalova-Iooss D., Folschweiller N., Dowell S.J., and Gearing K.L. Characterization of 16 human G protein-coupled receptors expressed in baculovirus-infected insect cells. Protein Expr. Purif. 44 (2005) 65-74
26. Dukkipati A., Vaclavikova J., Waghray D., and Garcia K.C. In vitro reconstitution and preparative purification of complexes between the chemokine receptor CXCR4 and its ligands SDF-1alpha, gp120-CD4 and AMD3100. Protein Expr. Purif. 50 (2006) 203-214
27. Skerra A., and Schmidt T.G. Applications of a peptide ligand for streptavidin: the Strep-tag. Biomol. Eng. 16 (1999) 79-86
28. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995) 277-293
29. Sklenar V., and Bax A. Spin-echo water suppression for the generation of pure-phase two-dimensional NMR-spectra. J. Magn. Reson. 74 (1987) 469-479
30. Dingley A.J., Mackay J.P., Chapman B.E., Morris M.B., Kuchel P.W., Hambly B.D., and King G.F. Measuring protein self-association using pulsed-field-gradient NMR spectroscopy: application to myosin light chain 2. J. Biomol. NMR 6 (1995) 321-328
31. Mirzabekov T., Kontos H., Farzan M., Marasco W., and Sodroski J. Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5. Nat. Biotechnol. 18 (2000) 649-654
32. Wu L., LaRosa G., Kassam N., Gordon C.J., Heath H., Ruffing N., Chen H., Humblias J., Samson M., Parmentier M., Moore J.P., and Mackay C.R. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J. Exp. Med. 186 (1997) 1373-1381
33. Mirzabekov T., Bannert N., Farzan M., Hofmann W., Kolchinsky P., Wu L., Wyatt R., and Sodroski J. Enhanced expression, native purification, and characterization of CCR5, a principal HIV-1 coreceptor. J. Biol. Chem. 274 (1999) 28745-28750
34. Appay V., Brown A., Cribbes S., Randle E., and Czaplewski L.G. Aggregation of RANTES is responsible for its inflammatory properties. Characterization of nonaggregating, noninflammatory RANTES mutants. J. Biol. Chem. 274 (1999) 27505-27512
35. Czaplewski L.G., McKeating J., Craven C.J., Higgins L.D., Appay V., Brown A., Dudgeon T., Howard L.A., Meyers T., Owen J., Palan S.R., Tan P., Wilson G., Woods N.R., Heyworth C.M., Lord B.I., Brotherton D., Christison R., Craig S., Cribbes S., Edwards R.M., Evans S.J., Gilbert R., Morgan P., Randle E., Schofield N., Varley P.G., Fisher J., Waltho J.P., and Hunter M.G. Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants. J. Biol. Chem. 274 (1999) 16077-16084
36. Zhao Y., and Sane D.C. Expression of a recombinant baculovirus for vitronectin in insect cells: purification, characterization of post-translational modifications and functional studies of the recombinant protein. Arch. Biochem. Biophys. 304 (1993) 434-442
37. Springael J.Y., Le Minh P.N., Urizar E., Costagliola S., Vassart G., and Parmentier M. Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers. Mol. Pharmacol. 69 (2006) 1652-1661
38. Terrillon S., and Bouvier M. Roles of G-protein-coupled receptor dimerization. EMBO Rep. 5 (2004) 30-34
39. Benkirane M., Jin D.Y., Chun R.F., Koup R.A., and Jeang K.T. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32. J. Biol. Chem. 272 (1997) 30603-30606